US Stock MarketDetailed Quotes

LRMR Larimar Therapeutics

Watchlist
  • 8.790
  • +0.790+9.88%
Trading Jun 3 12:39 ET
560.82MMarket Cap-9156P/E (TTM)

Larimar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-37.88%-10.41M
-21.36%-33.46M
-40.03%-9.34M
-56.52%-9.2M
1.62%-7.37M
-0.24%-7.55M
34.52%-27.57M
15.74%-6.67M
51.82%-5.88M
30.57%-7.49M
Net income from continuing operations
-124.55%-14.65M
-4.51%-36.95M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
30.18%-35.36M
-3.19%-9.43M
50.49%-8.32M
31.26%-8.67M
Depreciation and amortization
2.56%80K
-2.20%311K
3.85%81K
-1.30%76K
-6.17%76K
-4.88%78K
-2.45%318K
-11.36%78K
-12.50%77K
5.19%81K
Other non cash items
-79.17%-43K
-78.26%-82K
-33.33%-24K
46.15%-7K
-170.00%-27K
-380.00%-24K
-406.67%-46K
---18K
---13K
---10K
Change In working capital
215.90%2.66M
-250.45%-2.51M
31.29%2.31M
-288.52%-1.46M
-88.97%-1.06M
-660.26%-2.3M
-38.91%1.67M
581.64%1.76M
-74.69%775K
-240.15%-562K
-Change in prepaid assets
-173.32%-272K
-422.06%-1.07M
-515.38%-486K
-0.66%-612K
-168.28%-338K
278.37%371K
-106.36%-204K
-89.57%117K
-443.50%-608K
-61.42%495K
-Change in payables and accrued expense
210.44%2.95M
-177.36%-1.43M
72.31%2.82M
-162.38%-859K
33.83%-712K
-2,713.68%-2.67M
918.67%1.84M
211.22%1.64M
-52.19%1.38M
-11.39%-1.08M
-Change in other current assets
-416.67%-19K
-167.74%-21K
-600.00%-25K
66.67%10K
-163.16%-12K
500.00%6K
112.40%31K
101.27%5K
-95.52%6K
-90.95%19K
Cash from discontinued investing activities
Operating cash flow
-37.88%-10.41M
-21.36%-33.46M
-40.03%-9.34M
-56.52%-9.2M
1.62%-7.37M
-0.24%-7.55M
34.52%-27.57M
15.74%-6.67M
51.82%-5.88M
30.57%-7.49M
Investing cash flow
Cash flow from continuing investing activities
-174.11%-68.36M
136.67%33.35M
94.97%-2.63M
-1,272.04%-46.43M
72.16%-9.84M
92.25M
-476.35%-90.96M
-904.84%-52.23M
50.17%-3.38M
-283.89%-35.34M
Net PPE purchase and sale
----
-64.00%-164K
---164K
--0
----
----
69.97%-100K
--0
--0
----
Net investment purchase and sale
-174.11%-68.36M
136.89%33.52M
95.28%-2.47M
-1,272.04%-46.43M
72.08%-9.84M
--92.25M
-470.83%-90.86M
-903.72%-52.23M
47.92%-3.38M
-283.08%-35.24M
Cash from discontinued investing activities
Investing cash flow
-174.11%-68.36M
136.67%33.35M
94.97%-2.63M
-1,272.04%-46.43M
72.16%-9.84M
--92.25M
-476.35%-90.96M
-904.84%-52.23M
50.17%-3.38M
-283.89%-35.34M
Financing cash flow
Cash flow from continuing financing activities
162.15M
-99.96%30K
0
0
278.46%75.26M
-316K
Net common stock issuance
--162.15M
--0
--0
----
----
--0
278.46%75.26M
---316K
----
----
Proceeds from stock option exercised by employees
----
--30K
--0
----
----
----
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--162.15M
-99.96%30K
--0
-99.96%30K
--0
--0
278.46%75.26M
---316K
280.05%75.57M
--0
Net cash flow
Beginning cash position
-0.27%28.09M
-60.57%28.16M
-54.16%40.06M
353.90%95.66M
76.62%112.86M
-60.57%28.16M
2.80%71.44M
19.93%87.39M
-70.72%21.08M
0.58%63.9M
Current changes in cash
-1.56%83.38M
99.82%-76K
79.78%-11.97M
-183.85%-55.6M
59.83%-17.2M
1,224.37%84.7M
-2,320.22%-43.27M
-4,047.20%-59.22M
7,309.05%66.31M
-607.62%-42.83M
End cash Position
-1.24%111.46M
-0.27%28.09M
-0.27%28.09M
-54.16%40.06M
353.90%95.66M
76.62%112.86M
-60.57%28.16M
-60.57%28.16M
19.93%87.39M
-70.72%21.08M
Free cash flow
-37.88%-10.41M
-21.52%-33.62M
-42.49%-9.51M
-56.52%-9.2M
2.91%-7.37M
-0.24%-7.55M
34.80%-27.67M
15.83%-6.67M
52.95%-5.88M
29.84%-7.59M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -37.88%-10.41M-21.36%-33.46M-40.03%-9.34M-56.52%-9.2M1.62%-7.37M-0.24%-7.55M34.52%-27.57M15.74%-6.67M51.82%-5.88M30.57%-7.49M
Net income from continuing operations -124.55%-14.65M-4.51%-36.95M-37.86%-12.99M-8.94%-9.06M3.47%-8.37M27.03%-6.53M30.18%-35.36M-3.19%-9.43M50.49%-8.32M31.26%-8.67M
Depreciation and amortization 2.56%80K-2.20%311K3.85%81K-1.30%76K-6.17%76K-4.88%78K-2.45%318K-11.36%78K-12.50%77K5.19%81K
Other non cash items -79.17%-43K-78.26%-82K-33.33%-24K46.15%-7K-170.00%-27K-380.00%-24K-406.67%-46K---18K---13K---10K
Change In working capital 215.90%2.66M-250.45%-2.51M31.29%2.31M-288.52%-1.46M-88.97%-1.06M-660.26%-2.3M-38.91%1.67M581.64%1.76M-74.69%775K-240.15%-562K
-Change in prepaid assets -173.32%-272K-422.06%-1.07M-515.38%-486K-0.66%-612K-168.28%-338K278.37%371K-106.36%-204K-89.57%117K-443.50%-608K-61.42%495K
-Change in payables and accrued expense 210.44%2.95M-177.36%-1.43M72.31%2.82M-162.38%-859K33.83%-712K-2,713.68%-2.67M918.67%1.84M211.22%1.64M-52.19%1.38M-11.39%-1.08M
-Change in other current assets -416.67%-19K-167.74%-21K-600.00%-25K66.67%10K-163.16%-12K500.00%6K112.40%31K101.27%5K-95.52%6K-90.95%19K
Cash from discontinued investing activities
Operating cash flow -37.88%-10.41M-21.36%-33.46M-40.03%-9.34M-56.52%-9.2M1.62%-7.37M-0.24%-7.55M34.52%-27.57M15.74%-6.67M51.82%-5.88M30.57%-7.49M
Investing cash flow
Cash flow from continuing investing activities -174.11%-68.36M136.67%33.35M94.97%-2.63M-1,272.04%-46.43M72.16%-9.84M92.25M-476.35%-90.96M-904.84%-52.23M50.17%-3.38M-283.89%-35.34M
Net PPE purchase and sale -----64.00%-164K---164K--0--------69.97%-100K--0--0----
Net investment purchase and sale -174.11%-68.36M136.89%33.52M95.28%-2.47M-1,272.04%-46.43M72.08%-9.84M--92.25M-470.83%-90.86M-903.72%-52.23M47.92%-3.38M-283.08%-35.24M
Cash from discontinued investing activities
Investing cash flow -174.11%-68.36M136.67%33.35M94.97%-2.63M-1,272.04%-46.43M72.16%-9.84M--92.25M-476.35%-90.96M-904.84%-52.23M50.17%-3.38M-283.89%-35.34M
Financing cash flow
Cash flow from continuing financing activities 162.15M-99.96%30K00278.46%75.26M-316K
Net common stock issuance --162.15M--0--0----------0278.46%75.26M---316K--------
Proceeds from stock option exercised by employees ------30K--0--------------0--0--------
Cash from discontinued financing activities
Financing cash flow --162.15M-99.96%30K--0-99.96%30K--0--0278.46%75.26M---316K280.05%75.57M--0
Net cash flow
Beginning cash position -0.27%28.09M-60.57%28.16M-54.16%40.06M353.90%95.66M76.62%112.86M-60.57%28.16M2.80%71.44M19.93%87.39M-70.72%21.08M0.58%63.9M
Current changes in cash -1.56%83.38M99.82%-76K79.78%-11.97M-183.85%-55.6M59.83%-17.2M1,224.37%84.7M-2,320.22%-43.27M-4,047.20%-59.22M7,309.05%66.31M-607.62%-42.83M
End cash Position -1.24%111.46M-0.27%28.09M-0.27%28.09M-54.16%40.06M353.90%95.66M76.62%112.86M-60.57%28.16M-60.57%28.16M19.93%87.39M-70.72%21.08M
Free cash flow -37.88%-10.41M-21.52%-33.62M-42.49%-9.51M-56.52%-9.2M2.91%-7.37M-0.24%-7.55M34.80%-27.67M15.83%-6.67M52.95%-5.88M29.84%-7.59M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday+0.16%